Mereo BioPharma (MREO) Non-cash Items (2022 - 2025)

Mereo BioPharma (MREO) has 4 years of Non-cash Items data on file, last reported at $10.1 million in Q2 2025.

• Non-cash Items for Q2 2025 came in at $10.1 million, down 47.01% year-over-year; the trailing twelve-month figure through Jun 2025 was $10.1 million (down 47.01% YoY), and the FY2023 annual result was $1.2 million, up 116500.0% from the prior year.
• Non-cash Items grew to $10.1 million in Q2 2025 per MREO's latest filing, from $7.0 million in the prior quarter.
• Over five years, Non-cash Items peaked at $19.0 million in Q2 2024 and troughed at $1000.0 in Q4 2022.
• A 4-year average of $9.1 million and a median of $8.5 million in 2025 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2023 and 2025: Non-cash Items soared 116500.0% in 2023, then tumbled 59.88% in 2025.
• A 4-year view of Non-cash Items shows it stood at $1000.0 in 2022, then soared by 116500.0% to $1.2 million in 2023, then soared by 1527.36% to $19.0 million in 2024, then slumped by 47.01% to $10.1 million in 2025.
• Business Quant data shows MREO's Non-cash Items at $10.1 million in Q2 2025, $7.0 million in Q1 2025, and $19.0 million in Q2 2024.